Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 127,190 |
|
|||||
| News | (1) | ||||||
| Day High | 0.82 | Low High |
|||||
| Day Low | 0.69 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| PainReform Ltd | PRFX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.2485 | -25.33% | 0.7324 | 11:09:15 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.82 | 0.69 | 0.82 | 0.9809 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 525 | 127,190 | $ 0.7657102 | $ 97,391 | - | 0.69 - 26.41 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:09:15 | 250 | $ 0.7324 | USD |
PainReform Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.28M | 1.73M | - | 0 | -9.34M | -5.41 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
PainReform News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRFX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.97 | 2.55 | 0.69 | 1.49 | 1,397,334 | -1.24 | -62.82% |
| 1 Month | 1.88 | 2.55 | 0.69 | 1.50 | 379,372 | -1.15 | -61.04% |
| 3 Months | 2.09 | 2.55 | 0.69 | 1.54 | 134,287 | -1.36 | -64.96% |
| 6 Months | 2.40 | 3.36 | 0.69 | 1.72 | 76,169 | -1.67 | -69.48% |
| 1 Year | 5.90 | 26.41 | 0.69 | 8.49 | 397,985 | -5.17 | -87.59% |
| 3 Years | 34.40 | 78.40 | 0.69 | 21.28 | 367,836 | -33.67 | -97.87% |
| 5 Years | 66.70 | 78.40 | 0.69 | 24.04 | 332,715 | -65.97 | -98.90% |
PainReform Description
| PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. |
